Provided by Tiger Trade Technology Pte. Ltd.

Candel Therapeutics, Inc.

13.65
+0.78506.10%
Volume:568.84K
Turnover:7.71M
Market Cap:1.04B
PE:-9.48
High:13.70
Open:13.09
Low:12.97
Close:12.86
52wk High:13.82
52wk Low:4.35
Shares:76.52M
Float Shares:60.06M
Volume Ratio:0.80
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4390
EPS(LYR):-0.7210
ROE:-81.84%
ROA:-28.64%
PB:8.28
PE(LYR):-18.93

Loading ...

Aug 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2026

Major Issues Report

Form 8-K - Current report
Aug 13, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jun 29, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 29, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2026

Major Issues Report

Form 8-K - Current report
Jun 16, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2026

Major Issues Report

Form 8-K - Current report
Apr 27, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Mar 12, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2026

Major Issues Report

Form 8-K - Current report
Feb 23, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Major Issues Report

Form 8-K - Current report
Dec 05, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]